Literature DB >> 30842176

Short- and Long-term Outcomes of Surgical Treatment for Remnant Gastric Cancer After Distal Gastrectomy.

Y U Nakaji1, Hiroshi Saeki2, Kensuke Kudou1, Ryota Nakanishi1, Masahiko Sugiyama1, Yuichiro Nakashima1, Koji Ando1, Yoshinao Oda3, Eiji Oki1, Yoshihiko Maehara1.   

Abstract

BACKGROUND/AIM: Remnant gastric cancer (RGC) after distal gastrectomy occurs in 1-2% of patients, while the biological features of RGC are unknown. PATIENTS AND METHODS: A total of 22 consecutive patients with RGC who underwent total gastrectomy were analyzed. Their disease history included either gastric cancer (n=16) or peptic ulcer (n=6). Overall, 18 underwent open total gastrectomy (OTG) and 4 underwent laparoscopic total gastrectomy (LTG).
RESULTS: The mean number of lymph nodes dissected and metastatic lymph nodes was larger in the Ulcer group than in the Carcinoma group (p<0.005). The mean operation time was longer in the LTG than OTG (p<0.005). The median blood loss tended to be smaller in the LTG (p=0.090). Five-year overall and recurrence-free survival rates were 94% and 81%, respectively.
CONCLUSION: The status of lymph node metastasis after surgery for RGC should be cautiously considered in the context of disease history. Both LTG and OTG can be treatment options for RGC. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Remnant gastrectomy; laparoscopic operation; lymph node dissection; prognosis

Mesh:

Year:  2019        PMID: 30842176     DOI: 10.21873/anticanres.13256

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Current controversies in treating remnant gastric cancer: Are minimally invasive approaches feasible?

Authors:  Fu-Hai Ma; Hao Liu; Shuai Ma; Yang Li; Yan-Tao Tian
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.